Contact us
- Chongqing Industrial Design Promotion Center
- No. 1, Shangqingsi Road, Yuzhong District, Chongqing, People's Republic of China
- +86-23-60332626
- [email protected]

Chongqing-based Runsheng Pharma’s self-developed fluticasone propionate/salmeterol inhalation powder has received FDA approval, becoming the first Chinese enterprise to get FDA approval for an inhalation powder. The product treats asthma, developed over 12 years with over 1.2 billion yuan investment, passed FDA inspection with zero defects, and will benefit over 100 million asthma patients.
Qingling Motors breaks into the Mediterranean commercial vehicle market with customized strategy, overcoming the “impossible 45-degree slope challenge” long dominated by European and American brands. Chongqing’s auto exports reached RMB 53.03 billion in 2025, up 23% YoY.
Disclaimer: Unless otherwise stated for original content, articles and images are sourced from the internet and major mainstream media. Copyright belongs to the original authors. Please contact us for removal if infringement is suspected.
Liangjiang New Area, a top-tier national new area, implements a “Four-Core Synergy” industrial layout focusing on smart connected NEVs and next-gen electronics. It hosts 329 industrial enterprises, forming a “Two Pillars, Multiple Supports” industrial structure.
Western Science City Chongqing High-tech Zone is a core hub for sci-tech innovation in the Chengdu-Chongqing region. It focuses on 10 industrial chains including IC, NEV, and smart terminals, hosting over 285 industrial enterprises and building a comprehensive innovation ecosystem.